Cargando…

MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells

SIMPLE SUMMARY: We have investigated the transcriptional changes occurring in uveal and cutaneous melanoma cell lines upon depletion of MDMX (aka:MDM4). Computational analyses of the mRNAs/genes affected upon MDMX depletion determined that many were containing a p53-bindingsite, but even more contai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heijkants, Renier C., Teunisse, Amina F. A. S., de Jong, Danielle, Glinkina, Kseniya, Mei, Hailiang, Kielbasa, Szymon M., Szuhai, Karoly, Jochemsen, Aart G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496676/ https://www.ncbi.nlm.nih.gov/pubmed/36139642 http://dx.doi.org/10.3390/cancers14184482

Ejemplares similares

Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategies
por: Heijkants, R. C., et al.
Publicado: (2018)

Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts
por: Lenos, Kristiaan, et al.
Publicado: (2011)

Novel Treatments of Uveal Melanoma Identified with a Synthetic Lethal CRISPR/Cas9 Screen
por: Glinkina, Kseniya, et al.
Publicado: (2022)

Functions of MDMX in the Modulation of the p53-Response
por: Lenos, Kristiaan, et al.
Publicado: (2011)

Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma
por: Heijkants, Renier, et al.
Publicado: (2017)

Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma
por: Glinkina, Kseniya A., et al.
Publicado: (2023)

Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal Melanoma
por: Glinkina, Kseniya, et al.
Publicado: (2022)

Targeting Mdmx to treat breast cancers with wild-type p53
por: Haupt, S, et al.
Publicado: (2015)

Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target
por: Cao, Jinfeng, et al.
Publicado: (2018)

Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
por: Cao, Jinfeng, et al.
Publicado: (2016)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

Controlling the Mdm2-Mdmx-p53 Circuit
por: Waning, David L., et al.
Publicado: (2010)

MDMX elevation by a novel Mdmx–p53 interaction inhibitor mitigates neuronal damage after ischemic stroke
por: Yan, Haomin, et al.
Publicado: (2022)

Analysis of CRISPR‐Cas9 screens identifies genetic dependencies in melanoma
por: Christodoulou, Eirini, et al.
Publicado: (2020)

Mdmx promotes genomic instability independent of p53 and Mdm2
por: Carrillo, Alexia M., et al.
Publicado: (2014)

Mouse modelling of the MDM2/MDMX−p53 signalling axis
por: Tackmann, Nicole R., et al.
Publicado: (2017)

The MDM2/MDMX/p53 axis in the adaptive stress response
por: Wang, Bing, et al.
Publicado: (2020)

The roles and regulation of MDM2 and MDMX: it is not just about p53
por: Klein, Alyssa M., et al.
Publicado: (2021)

Is MDMX the better target?
por: Kon, Ning, et al.
Publicado: (2018)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Role of the N-terminal lid in regulating the interaction of phosphorylated MDMX with p53
por: Chan, Jane Vin, et al.
Publicado: (2017)

The p53/MDM2/MDMX-targeted therapies—a clinical synopsis
por: Jiang, Liren, et al.
Publicado: (2020)

MDMX phosphorylation-dependent p53 downregulation contributes to an immunosuppressive tumor microenvironment
por: Wang, Bing, et al.
Publicado: (2020)

Breast cancer dormancy is associated with a 4NG1 state and not senescence
por: Prunier, Chloé, et al.
Publicado: (2021)

Predicted Functions of MdmX in Fine-Tuning the Response of p53 to DNA Damage
por: Kim, Sohyoung, et al.
Publicado: (2010)

Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB
por: Hernández-Monge, Jesús, et al.
Publicado: (2016)

Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen
por: Qin, Jiang-Jiang, et al.
Publicado: (2017)

Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions
por: Blackburn, Tim J., et al.
Publicado: (2013)

Amplification of Mdmx and overexpression of MDM2 contribute to mammary carcinogenesis by substituting for p53 mutations
por: Yu, Qiong, et al.
Publicado: (2014)

USP22 Promotes NSCLC Tumorigenesis via MDMX Up-Regulation and Subsequent p53 Inhibition
por: Ding, Fangbao, et al.
Publicado: (2014)

Insight Into the Binding Mechanism of p53/pDIQ-MDMX/MDM2 With the Interaction Entropy Method
por: Li, Mengxin, et al.
Publicado: (2019)

p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX
por: Levy, Robin, et al.
Publicado: (2019)

Leveraging the multivalent p53 peptide-MdmX interaction to guide the improvement of small molecule inhibitors
por: Cheng, Xiyao, et al.
Publicado: (2022)

A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein
por: Valianatos, Georgios, et al.
Publicado: (2017)

Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma
por: Sand, Laurens G. L., et al.
Publicado: (2017)

MDM4 (MDMX) and its Transcript Variants
por: Mancini, F, et al.
Publicado: (2009)

Role of Mdm2 and Mdmx in DNA repair
por: Eischen, Christine M.
Publicado: (2017)

Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells
por: Egorova, Olga, et al.
Publicado: (2020)

Stress-Induced Alternative Splice Forms of MDM2 and MDMX Modulate the p53-Pathway in Distinct Ways
por: Jacob, Aishwarya G., et al.
Publicado: (2014)

Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry
por: Zhu, Yan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l0vmclpptdebioe0b6rl43uhkq